ÂÜÀòÂÒÂ×

Carol Patterson, Ph.D. has extensive experience in the pharmaceutical industry, particularly in the field of regulatory affairs. Carol currently serves as the Global Head of Regulatory Affairs CMC at Blueprint Medicines, starting in August 2020. Prior to this, they held various roles at Allergan from 2013 to 2020, including AVP of Global Regulatory Affairs and Senior Director/Executive Director of Global Regulatory Affairs CMC. At Allergan, they played a key role in global regulatory strategy, led development projects, managed teams, conducted negotiations with health authorities, and ensured regulatory compliance. Before joining Allergan, Dr. Patterson worked at Endo Pharmaceuticals for over a decade, where they served as the Sr. Director of Regulatory Affairs and later as the Director of Regulatory Affairs. During their time at Endo Pharmaceuticals, they successfully built and structured a diverse and efficient regulatory affairs team, implemented staff development programs, provided strategic guidance, performed risk analysis and gap analysis, and contributed to due diligence activities.

Carol Patterson, Ph.D. holds a Master's degree in Chemistry from New York University. Carol also has a Doctor of Philosophy (Ph.D.) in Organization and Management with a specialization in Leadership from Capella University. In addition to their educational background, they have also obtained certifications in Leadership from Capella University and Negotiation from The Wharton School.